S. Lambrechts

van der Ploeg, P., Hendrikse, C. SE., Thijs, A. MJ., Westgeest, H. M., Smedts, H. PM., Vos, M. C., Jalving, M., Lok, C. AR., Boere, I. A., van Ham, M. APC., Ottevanger, P. B., Westermann, A. M., Mom, C. H., Lalisang, R. I., Lambrechts, S., Bekkers, R. LM., & Piek, J. MJ. (2024). Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol. Heliyon, 10(1), Article e23170. https://doi.org/10.1016/j.heliyon.2023.e23170

Hendrikse, C. S. E., van der Ploeg, P., van de Kruis, N. M. A., Wilting, J. H. C., Oosterkamp, F., Theelen, P. M. M., Lok, C. A. R., de Hullu, J. A., Smedts, H. P. M., Vos, M. C., Pijlman, B. M., Kooreman, L. F. S., Bulten, J., Lentjes-Beer, M. H. F. M., Bosch, S. L., van de Stolpe, A., Lambrechts, S., Bekkers, R. L. M., & Piek, J. M. J. (2023). Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low-grade ovarian carcinoma. Cancer, 129(9), 1361-1371. https://doi.org/10.1002/cncr.34661

Hendrikse, C. S. E., Theelen, P. M. M., van der Ploeg, P., Westgeest, H. M., Boere, I. A., Thijs, A. M. J., Ottevanger, P. B., van de Stolpe, A., Lambrechts, S., Bekkers, R. L. M., & Piek, J. M. J. (2023). The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis. Gynecologic Oncology, 171(1), 83-94. https://doi.org/10.1016/j.ygyno.2023.01.038

Zelisse, H. S., van Gent, M., de Ridder, S., van der Aa, M. A., van Altena, A. M., Bart, J., Belien, J. A. M., Boere, I. A., Bosch, S. L., Broeks, A., Bulten, J., Collee, M., Groenendijk, F. H., Horlings, H., Jansen, M. P. H. M., Jonges, G. N., Kooreman, L., de Kroon, C. D., Lambrechts, S., ... Dijk, F. (2023). Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research. Gynecologic and Obstetric Investigation, 87(6), 389-397. https://doi.org/10.1159/000528330

Burg, L. C., Kruitwagen, R. F. P. M., de Jong, A., Bulten, J., Bonestroo, T. J. J., Kraayenbrink, A. A., Boll, D., Lambrechts, S., Smedts, H. P. M., Bouman, A., Engelen, M. J. A., Kasius, J. C., Bekkers, R. L. M., & Zusterzeel, P. L. M. (2023). Sentinel Lymph Node Mapping in Presumed Low- and Intermediate-Risk Endometrial Cancer Management (SLIM): A Multicenter, Prospective Cohort Study in The Netherlands. Cancers, 15(1), Article 271. https://doi.org/10.3390/cancers15010271

van der Ploeg, P., Uittenboogaard, A., Bosch, S. L., van Diest, P. J., Wesseling-Rozendaal, Y. J. W., van de Stolpe, A., Lambrechts, S., Bekkers, R. L. M., & Piek, J. M. J. (2022). Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium. Gynecologic Oncology, 165(1), 114-120. https://doi.org/10.1016/j.ygyno.2022.01.027

Verkouteren, B. J. A., Cosgun, B., Reinders, M. G. H. C., Kessler, P. A. W. K., Vermeulen, R. J., Klaassens, M., Lambrechts, S., van Rheenen, J. R., van Geel, M., Vreeburg, M., & Mosterd, K. (2022). A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome). British Journal of Dermatology, 186(2), 215-226. https://doi.org/10.1111/bjd.20700

van der Ploeg, P., Uittenboogaard, A., Bucks, K. M. M., Lentjes-Beer, M. H. F. M., Bosch, S. L., van Rumste, M. M. E., Vos, M. C., van Diest, P. J., Lambrechts, S., van de Stolpe, A., Bekkers, R. L. M., & Piek, J. M. J. (2022). Cyclic activity of signal transduction pathways in fimbrial epithelium of the human fallopian tube. Acta Obstetricia et Gynecologica Scandinavica, 101(2), 256-264. https://doi.org/10.1111/aogs.14306

Ubachs, J., van de Worp, W. R. P. H., Vaes, R. D. W., Pasmans, K., Langen, R. C., Meex, R. C. R., van Bijnen, A. A. J. H. M., Lambrechts, S., Van Gorp, T., Kruitwagen, R. F. P. M., Damink, S. W. M. O., & Rensen, S. S. (2022). Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients. Journal of cachexia, sarcopenia and muscle, 13(1), 311-324. https://doi.org/10.1002/jcsm.12885

van der Ploeg, P., Uittenboogaard, A., Thijs, A. M. J., Westgeest, H. M., Boere, I. A., Lambrechts, S., van de Stolpe, A., Bekkers, R. L. M., & Piek, J. M. J. (2021). The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis. Gynecologic Oncology, 163(2), 433-444. https://doi.org/10.1016/j.ygyno.2021.07.008